Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- GI 2.0: The Playbook | Industry Perspectives
- Disorders of Gut–Brain Interaction and the Rome V Process (Gastroenterology)
- Physician triage changed management in nearly 1 in 4 GI referrals (GI & Hepatology News)
- Upper GI Disorders: New Evidence May Refine Clinical Practice (Medscape)
- Pennsylvania Sues Chatbot Over Claims It Impersonates Doctors (MedCity News)
- Physician independence vanishes as corporate medicine swallows up U.S. health care (Medical Economics)
- Oshi Health Appoints Danny Krifcher as President and Chief Operating Officer (PR Newswire)
- Better onboarding may help GI practices retain APPs (GI & Hepatology News)
